14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
Sep 12, 2023 $0.0700 $0.0860 $0.0688 $0.0843 2 936 413
Sep 11, 2023 $0.0940 $0.0940 $0.0854 $0.0865 554 795
Sep 08, 2023 $0.0922 $0.0942 $0.0850 $0.0867 989 491
Sep 07, 2023 $0.0945 $0.0962 $0.0903 $0.0941 751 516
Sep 06, 2023 $0.0937 $0.100 $0.0837 $0.0885 1 228 400
Sep 05, 2023 $0.0940 $0.0980 $0.0890 $0.0970 1 684 559
Sep 01, 2023 $0.0901 $0.0920 $0.0827 $0.0866 616 456
Aug 31, 2023 $0.0849 $0.0920 $0.0813 $0.0910 1 521 309
Aug 30, 2023 $0.0960 $0.0960 $0.0821 $0.0875 2 596 039
Aug 29, 2023 $0.0820 $0.0900 $0.0791 $0.0806 2 212 621
Aug 28, 2023 $0.0854 $0.0880 $0.0790 $0.0790 1 369 035
Aug 25, 2023 $0.0860 $0.0880 $0.0800 $0.0880 1 474 612
Aug 24, 2023 $0.0930 $0.0930 $0.0812 $0.0880 1 292 429
Aug 23, 2023 $0.0914 $0.0980 $0.0881 $0.0900 1 662 911
Aug 22, 2023 $0.0985 $0.0985 $0.0874 $0.0880 1 593 502
Aug 21, 2023 $0.0980 $0.0980 $0.0900 $0.0980 1 545 288
Aug 18, 2023 $0.100 $0.106 $0.0930 $0.0951 1 887 544
Aug 17, 2023 $0.110 $0.120 $0.101 $0.101 5 234 527
Aug 16, 2023 $0.0850 $0.113 $0.0850 $0.110 4 784 209
Aug 15, 2023 $0.0900 $0.0987 $0.0860 $0.0881 2 365 844
Aug 14, 2023 $0.0936 $0.0999 $0.0936 $0.0980 1 193 846
Aug 11, 2023 $0.106 $0.106 $0.0955 $0.101 1 216 683
Aug 10, 2023 $0.100 $0.110 $0.100 $0.109 2 210 708
Aug 09, 2023 $0.119 $0.120 $0.0939 $0.115 9 915 294
Aug 08, 2023 $0.147 $0.186 $0.131 $0.131 115 098 387
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT